Controversial New Alzheimer’s Drug Approved Despite Reservations

 ========= Old Image Removed =========1Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2021/06/Alzheimers_Sign-e1623261590289.jpg
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:5:{s:5:"width";i:1200;s:6:"height";i:675;s:4:"file";s:42:"2021/06/Alzheimers_Sign-e1623261590289.jpg";s:5:"sizes";a:10:{s:6:"medium";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-336x189.jpg";s:5:"width";i:336;s:6:"height";i:189;s:9:"mime-type";s:10:"image/jpeg";}s:5:"large";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-771x434.jpg";s:5:"width";i:771;s:6:"height";i:434;s:9:"mime-type";s:10:"image/jpeg";}s:9:"thumbnail";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-140x140.jpg";s:5:"width";i:140;s:6:"height";i:140;s:9:"mime-type";s:10:"image/jpeg";}s:12:"medium_large";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-768x432.jpg";s:5:"width";i:768;s:6:"height";i:432;s:9:"mime-type";s:10:"image/jpeg";}s:9:"wbhm-icon";a:4:{s:4:"file";s:40:"Alzheimers_Sign-e1623261590289-80x80.jpg";s:5:"width";i:80;s:6:"height";i:80;s:9:"mime-type";s:10:"image/jpeg";}s:13:"wbhm-featured";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-800x450.jpg";s:5:"width";i:800;s:6:"height";i:450;s:9:"mime-type";s:10:"image/jpeg";}s:20:"wbhm-featured-square";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-600x600.jpg";s:5:"width";i:600;s:6:"height";i:600;s:9:"mime-type";s:10:"image/jpeg";}s:18:"wbhm-featured-home";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-553x311.jpg";s:5:"width";i:553;s:6:"height";i:311;s:9:"mime-type";s:10:"image/jpeg";}s:22:"wbhm-featured-carousel";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-470x265.jpg";s:5:"width";i:470;s:6:"height";i:265;s:9:"mime-type";s:10:"image/jpeg";}s:14:"post-thumbnail";a:4:{s:4:"file";s:42:"Alzheimers_Sign-e1623261590289-125x125.jpg";s:5:"width";i:125;s:6:"height";i:125;s:9:"mime-type";s:10:"image/jpeg";}}s:10:"image_meta";a:12:{s:8:"aperture";s:1:"0";s:6:"credit";s:0:"";s:6:"camera";s:0:"";s:7:"caption";s:0:"";s:17:"created_timestamp";s:1:"0";s:9:"copyright";s:0:"";s:12:"focal_length";s:1:"0";s:3:"iso";s:1:"0";s:13:"shutter_speed";s:1:"0";s:5:"title";s:0:"";s:11:"orientation";s:1:"0";s:8:"keywords";a:0:{}}}
        )

    [_media_credit] => Array
        (
            [0] => The Alzheimer's Association
        )

    [_navis_media_credit_org] => Array
        (
            [0] => Flickr
        )

    [_navis_media_can_distribute] => Array
        (
            [0] => 1
        )

    [_wp_attachment_backup_sizes] => Array
        (
            [0] => a:11:{s:9:"full-orig";a:3:{s:5:"width";i:1200;s:6:"height";i:803;s:4:"file";s:19:"Alzheimers_Sign.jpg";}s:14:"thumbnail-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-140x140.jpg";s:5:"width";i:140;s:6:"height";i:140;s:9:"mime-type";s:10:"image/jpeg";}s:11:"medium-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-336x225.jpg";s:5:"width";i:336;s:6:"height";i:225;s:9:"mime-type";s:10:"image/jpeg";}s:17:"medium_large-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-768x514.jpg";s:5:"width";i:768;s:6:"height";i:514;s:9:"mime-type";s:10:"image/jpeg";}s:10:"large-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-771x516.jpg";s:5:"width";i:771;s:6:"height";i:516;s:9:"mime-type";s:10:"image/jpeg";}s:14:"wbhm-icon-orig";a:4:{s:4:"file";s:25:"Alzheimers_Sign-80x80.jpg";s:5:"width";i:80;s:6:"height";i:80;s:9:"mime-type";s:10:"image/jpeg";}s:18:"wbhm-featured-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-800x450.jpg";s:5:"width";i:800;s:6:"height";i:450;s:9:"mime-type";s:10:"image/jpeg";}s:25:"wbhm-featured-square-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-600x600.jpg";s:5:"width";i:600;s:6:"height";i:600;s:9:"mime-type";s:10:"image/jpeg";}s:23:"wbhm-featured-home-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-465x311.jpg";s:5:"width";i:465;s:6:"height";i:311;s:9:"mime-type";s:10:"image/jpeg";}s:27:"wbhm-featured-carousel-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-396x265.jpg";s:5:"width";i:396;s:6:"height";i:265;s:9:"mime-type";s:10:"image/jpeg";}s:19:"post-thumbnail-orig";a:4:{s:4:"file";s:27:"Alzheimers_Sign-125x125.jpg";s:5:"width";i:125;s:6:"height";i:125;s:9:"mime-type";s:10:"image/jpeg";}}
        )

)
1654886250 
1623157204

Follow via Flickr Link: https://www.flickr.com/photos/alzmglc/15311519476/in/photolist-pk2xi7-p5zz1T-pn36eW-pk2z4G-pn4Zzt-p5yHLJ-p5yCyQ-p5yy7H-p5yKrY-p5zBtP-pn2YxE-pn4BVM-p5ztkA-pmMonT-p5ziQo-bxQfpz-pmMxTM-p5zXeR-p5zbib-p5zQFk-pn3m45-pk2Tsf-p5zB8E-pn4N6g-4eGjGS-CFX1-pk2JQf-WfWjgu-pk2Lc3-3hQn2G-4kkzZx-6DojR2-51m44-7rJbFK-9YAmBr-fkWSC9-44Aksc-nSqng6-GAH7BD-j1M1Sk-gv1YhP-6Doi7x-3xK9k-6DoitF-dwaKm8-fkWSGw-6DoiYK-6DssxN-MhcFWN-o17RFw

The Alzheimer's Association, Flickr

The U.S. Food and Drug Administration has approved the first new drug for Alzheimer’s disease in 20 years, but some doctors, including one at UAB, warned patients’ families not to expect much from the drug any time soon.

The drug, aducanumab, is expected to help slow the progression of the disease, but not to improve current memory impairments, according to a release from the University of Alabama at Birmingham. The university’s Division of Memory Disorders and the Alzheimer’s Disease Center have been involved in clinical trials of aducanumab for the past five years.

“The approval of the first disease-modifying therapy is a milestone for our field and a result of years of intense research. However, it must be understood that [aducanumab] is not expected to restore memory or reverse the symptoms of Alzheimer’s disease,” said Dr. David Geldmacher, professor of neurology at UAB and clinical core director of the center. “Instead, it is expected to slow the worsening of the disease. [Aducanumab] is likely the beginning of a new era in treating AD, but not the end of the story.”

Geldmacher said it would be some time before the drug is widely available, not all patients will be eligible to receive it, and many patients, especially with advanced disease, are not likely to see improvement from it.

The FDA approved the drug despite opposition from an independent advisory committee and some Alzheimer’s experts who said there was not enough evidence the drug helps patients, according to several news reports, including from the Associated Press.

The FDA did require the drugmaker, Biogen, to conduct another study to determine whether it benefits patients, and it could pull the drug from the market if its effectiveness is not proven.

Editor’s Note: UAB holds WBHM’s broadcast license, but our news and business departments operate independently.

 

How a forgotten tape recorder led to Tunde Adebimpe’s debut album

The TV on the Radio cofounder talks about making Thee Black Boltz.

A dad accused of killing his 3 young daughters is on the run. Here’s what to know

Travis Decker is accused of suffocating his daughters during a recent camping trip in Washington. Authorities say the Army veteran is "well versed in wilderness survival" and considered dangerous.

Islam is the fastest growing religion in the world, Pew study says

The Pew report reveals how religious disaffiliation and population growth have influenced the global religious landscape.

Canceled climate grants would have cut pollution while boosting production, jobs at two Alabama ironworks

The U.S. Department of Energy rescinded $3.7 billion in clean energy grants last month, saying the projects selected would not generate a positive return on investment.

Cold case mystery ‘Dept. Q’ focuses more on the characters than crime

An Edinburgh police detective and a team of misfits search for a woman who vanished several years earlier. Critic John Powers says the byplay of characters makes Dept. Q worth watching.

Gunman kills 9 in a mass shooting at a school in Austria

"There are no words to describe the pain, the disbelief and the grief that all of Austria feels right now," said the country's Chancellor Christian Stocker. "Our country has fallen silent in horror."

More BirminghamWatch Coverage